Seven out of the 13 splice variant biomarkers, including C5ORF4, COPZ1, MACF1, WLS, PRG3, ZNF160 and EFTUD2, were replicated in blood samples obtained from an independent clinical trial, thus strengthening the association of aberrant splicing in PD [28]. This evidence concerns the gene MACF1 and Parkinson disease.